HMI
  • About
    • Who we are?
    • Mission
    • Traditions & History
    • Partnerships
    • Advisory Council
    • Giving
      • Support the HMI now
        • Applied-Microbiology Programs
        • Disease-Specific Research Programs
        • Longevity and Aging Research Program
        • General support of HMI
      • Ways to give
      • Your impact
      • Naming opportunities
  • Research
    • Applied microbiology programs
      • Bacteriophages as New Human Viral Pathogens
      • Prion-like Domains in Eukaryotic Viruses
      • Novel bacterial species
      • The core human microbiome
      • Novel Bacterial Pathogens of Humans
      • Antimicrobial resistance | Sporobiota | Sporobiome
      • Regulators of the Microbiota (NLGE)
    • Disease-specific Research Programs
      • Parkinson’s disease
      • Alzheimer’s disease
      • Amyotrophic Lateral Sclerosis
      • Autism
      • Multiple sclerosis
      • Oncology
      • Type 1 Diabetes
      • Age-related Infectious Diseases
      • Antibiotic resistance/Novel Diagnostic Systems
      • Jewish Research
      • Other Focus Areas
    • Longevity and Aging Research Program
  • Therapeutic Areas
  • For Scientists
    • Theories Developed by the HMI
      • Microbiota diseases
      • The Pangenome concept
      • Tetz’s theory of longevity
      • Maternal Inheritance of the Microbiota
      • Neurodegenerative diseases theory
      • Genetic Predisposition in Jewish Population
    • HMI Database
      • Kluyvera intestini sp. nov. GT-16
      • Bacillus sp. VT 712
      • Acinetobacter sp. nov. VT-511
      • Bacilli bacteriumgen. nov. sp. nov. VT-13-104
      • Paenibacillus sp. nov. VT 400
      • Streptococcus sp. nov. VT 162
    • Publications
  • Education
  • Newsroom
    • News from the HMI
    • For Journalists
  • Contact

Bacillus respiratoriisp. nov. VT-16-64

  • HMI Database
  • Chryseo bacterium mucoviscidosis sp. nov. VT16-26
  • Tetzosporiumhominis gen. nov. sp. nov. VT-49
  • Bacillus intestinalis sp. nov.
  • Bacillus respiratoriisp. nov. VT-16-64
  • Bacillus obstructivus sp. nov. VT-16-70
  • Kluyvera intestini sp. nov. GT-16
  • Bacillus sp. nov. VT 712
  • Acinetobacter sp. nov. VT-511
  • Bacilli bacteriumgen. nov. sp. nov. VT-13-104
  • Paenibacillus sp. nov. VT 400
  • Streptococcus sp. nov. VT 162
  • Chryseo bacterium mucoviscidosis sp. nov. VT16-26
  • Tetzosporiumhominis gen. nov. sp. nov. VT-49
  • Bacillus intestinalis sp. nov.
  • Bacillus respiratoriisp. nov. VT-16-64
  • Bacillus obstructivus sp. nov. VT-16-70
  • Kluyvera intestini sp. nov. GT-16
  • Bacillus sp. nov. VT 712
  • Acinetobacter sp. nov. VT-511
  • Bacilli bacteriumgen. nov. sp. nov. VT-13-104
  • Paenibacillus sp. nov. VT 400
  • Streptococcus sp. nov. VT 162
HMI
101 6th avenue, New York, NY, 10013 (at the JLabs)
Email: info@hmi-us.com
Monday — Friday 8:30 AM — 6:00 PM EST

All Rights Reserved.
Terms of Use | Privacy Policy
About
  • Who we are?
  • Mission
  • Traditions & History
  • Partnerships
  • Advisory Council
  • Giving
Research
  • Applied microbiology programs
  • Disease-specific Research Programs
  • Longevity and Aging Research Program
SCIENTIFIC COMMUNITY
  • Theories Developed by the HMI
  • HMI Database
  • Publications
EDUCATION
  • Education
NEWS
  • News from the HMI
Information
  • Contact with us
  • Privacy Policy
  • Terms of Use